NFkappaB is a key player in the crosstalk between inflammation and cardiovascular diseases

A Fiordelisi, G Iaccarino, C Morisco, E Coscioni… - International journal of …, 2019 - mdpi.com
Inflammation is a key mechanism of cardiovascular diseases. It is an essential component of
atherosclerosis and a significant risk factor for the development of cardiovascular events. In …

G protein-coupled receptor kinase 2 (GRK2) as a potential therapeutic target in cardiovascular and metabolic diseases

C Murga, AC Arcones, M Cruces-Sande… - Frontiers in …, 2019 - frontiersin.org
G protein-coupled receptor kinase 2 (GRK2) is a central signaling node involved in the
modulation of many G protein-coupled receptors (GPCRs) and also displaying regulatory …

Inflammation and cardiovascular diseases: the most recent findings

D Sorriento, G Iaccarino - International journal of molecular sciences, 2019 - mdpi.com
The series of reactive biological events that we identify as inflammation has been
investigated in recent years and unveiled as an important mechanism for regeneration. The …

Ketone bodies rescue mitochondrial dysfunction via epigenetic remodeling

J Gambardella, SS Jankauskas, U Kansakar… - Basic to Translational …, 2023 - jacc.org
Ischemic cardiac disease is a major cause of mortality worldwide. However, the exact
molecular processes underlying this disorder are not fully known. This study includes a …

An essential role for Wnt/β-catenin signaling in mediating hypertensive heart disease

Y Zhao, C Wang, C Wang, X Hong, J Miao, Y Liao… - Scientific reports, 2018 - nature.com
Activation of the renin-angiotensin system (RAS) is associated with hypertension and heart
disease. However, how RAS activation causes cardiac lesions remains elusive. Here we …

Inflammatory mediators in a short-time mouse model of doxorubicin-induced cardiotoxicity

M Pecoraro, M Del Pizzo, S Marzocco… - Toxicology and applied …, 2016 - Elsevier
Doxorubicin (DOXO) is commonly used to treat a wide range of malignant tumors, but its
clinical use is limited by acute and chronic cardiotoxicity. The precise mechanism underlying …

Adrenergic signaling in heart failure and cardiovascular aging

G Santulli, G Iaccarino - Maturitas, 2016 - Elsevier
Both cardiovascular disease and aging are associated with changes in the sympathetic
nervous system. Indeed, mounting evidence indicates that adrenergic receptors are …

Interdependence of anti-inflammatory and antioxidant properties of squalene–implication for cardiovascular health

NI Ibrahim, I Naina Mohamed - Life, 2021 - mdpi.com
Cardiovascular diseases (CVD) have been recognized as the leading cause of mortality
worldwide, accounting for 31% of global mortality. Among the risk factors of CVD …

Heart failure in diabetes

SS Jankauskas, U Kansakar, F Varzideh, S Wilson… - Metabolism, 2021 - Elsevier
Heart failure and cardiovascular disorders represent the leading cause of death in diabetic
patients. Here we present a systematic review of the main mechanisms underlying the …

Targeting mediators of inflammation in heart failure: a short synthesis of experimental and clinical results

TM Szabo, A Frigy, EE Nagy - International Journal of Molecular Sciences, 2021 - mdpi.com
Inflammation has emerged as an important contributor to heart failure (HF) development and
progression. Current research data highlight the diversity of immune cells, proteins, and …